Bluebird whistles up a co-development/co-promotion pact with Celgene on bb2121 CAR-T
Having worked together over the past 5 years, bluebird says it will cover half of the development costs for bb2121, beginning in April, while looking to split the profits it generates in the US. Celgene is in control outside the US.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.